Middle East and North Africa (MENA) new HIV cases show the highest increase among all regions in the world. Even though Egypt has a low prevalence among the general population (< 0.02%), a national HIV epidemic occurs in certain population risk groups. The current study was conducted to asses clinical and immunological disease progression; following up viral load (VL) and detecting delta32 CCR5 genotype polymorphism in selected cases, determining unemployment rate and identify predictors of employment for HIVcases. A cross sectional design was adopted. HIV infected cases attending Alexandria Fever Hospital (AFH) for one year. Interview questionnaire and four CD+4 counts were done for all patients, HIV VL and delta32 CCR5 polymorphism were done for selected cases. Sexual transmis sion and drug abuse are the most important risk factors. Infectious comorbidity increases the rate of HIV progression. CD4+ count at the end of the study; CD+4 (4), count was significantly higher than all other CD4+ readings among the whole cohort and among the treated group. Also, VL at the end of the study; VL(2), was significantly higher than VL(1) among the untreated group. Unemployment rate was 40%. Male gender and obtaining vocational training were significant predictors of employment. It can be concluded that having a family member living with HIV and drug abusers are high risk groups for HIV acquisition. Factors responsible for progression of HIV should be further investigated. Antiretroviral therapy is very effective in checking HIV replication rate, delaying the progression of HIV, reconstitut ing the immune response and should be available for all cases detected.
Introduction
Globally people living with HIV (PLHIV) numbered around 36.7 million at the end of 2015 according to the latest United Nations Acquired Immune Deficiency Syndrome (UNAIDS) 2016 data covering 160 countries (Global AIDS Update 2016 | UNAIDS, 2016 . The burden of the epidemic continues to vary considerably bet ween countries and regions. New HIV infections in the Mid dle East and North Africa (MENA) region have incre ased by 31% since 2001, which is the highest increase among all regions in the world (Gokengin et al., 2016) .
In Egypt, the estimated number of PLHIV is around 11,000 individuals (7,000-19,000) with overall low pre valence among the general population (< 0.02%). Greater Cairo and Alexandria; which have about one third of the population of the country, account for almost two thirds of all HIV infected patients detected. Egypt has a national epidemic concentrated in two key populations; people who inject drugs (PWID) and men who have sex with men (MSM) (Egypt National AIDS program NAP, 2015) . Egyptian National guidelines on clinical care and antiretroviral therapy (ART) states that Care begins with CD4 cell count testing and those with CD4 count of 500 or lower are eligible for ART (National Guideline on Clinical Care and Antiretroviral Drugs for Treating and Preventing HIV Infection, Egypt, 2014) .
HIV has a variable rate (spectrum) of progression in infected people. This variation in disease development is one parameter that led to the classification of patients as rapid progressors (RPs), slow/intermediate progressors, controllers; elite controllers (EC), viraemic controllers
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Progression and Unemployment Rate among Patients from Alexandria, Egypt (VC) and longterm nonprogressors (LTNPs). The clas sification is also based on CD4 count, HIV viral load (VL), and ART. Different studies suggested different definitions to these subgroups . Understanding mechanisms for significantly delay ing disease progression remains a worthwhile research goal. Nonprogression probably results from multiple virol ogic, immunologic, and genetic factors. In terms of host genetics, some LTNPs display polymorphisms in chemo kine receptors (CCR5 and CXCR4) and chemo kines (e.g. MIP1α and RANTES). Nearly 11% of Cauca sians and 2% of Blacks are homozygous for the CCR5 delta32 mutation (Poropatich and Sullivan, 2011) .
Employment status is a major predictor of health status and living conditions. However, unemployment rate among HIV -cases ranges from 45% to 65%. It is still higher compared with the general population, in many countries including highincome ones (Legarth et al., 2014) . Women, younger age, poor educational level, progressed HIV infections, or Hepatitis C virus (HCV) coinfection are risk factors for unemployment among HIVcases (Gros et al., 2016) .
Our study aimed at (1) assessing clinical and immu nological disease progression; (2) evaluating and fol lowing up the VL of selected cases, (3) detecting delta 32 CCR5 genotype polymorphism in selected cases, (4) determining unemployment rate and identify predic tors of employment for HIVcases.
Experimental

Material and Methods
A cross sectional design was adopted. All HIV infected cases attending Alexandria Fever Hospital (AFH) during field work period of the study from Janu ary to December 2015, who agreed to participate in the study were included (n = 150). Patients were excluded if they were younger than 18 years or refused to par ticipate. They were diagnosed earlier by AFH protocol for HIV diagnosis (National Guideline on Clinical Care and Antiretroviral Drugs for Treating and Preventing HIV Infection, Egypt, 2014).
Study tools. An interview questionnaire. A pre designed questionnaire was used to obtain data from all HIV infected patients (n = 150) concerning a) socio demography, b) risk factors, c) health status, d) his tory of the disease and e) treatment regimens of the participants.
Laboratory investigations
Blood samples were collected and analyzed at the AFH and Alexandria Faculty of Medicine (AFM) Cen tral Laboratories.
The immunological status of the participants (CD4 count). CD4 + Tcell count (cells/mm 3 ) was taken as an immunological marker in the course of disease progression. Five CD4 counts were performed for all patients (n = 150): CD4+ (0); earliest CD4+ Tcell count (on diagnosis of HIV), CD4+ (1); CD4+ measured at the beginning of the study, CD4+(2); CD4+ measured after 3 months of the study, CD4+(3); CD4+ measured after 6 months of the study, CD4+(4); CD4+ measured after 9 months of the study.
Whole blood (200 μl) was collected in EDTA vacu tainer tubes (BectonDickinson Mt View, California,). The PartecCyFlow Counter® (Partec GmbH, Munster, Germany) for CD4+ Tcell enumeration was used for performing the CD4 count. The Partec CD4% Reagent kit consists of MEM24; a monoclonal antibody, which recognizes human CD4 antigen (Manasa et al., 2007) .
HIV viral load. VL was done twice to selected cases (n = 20). First VL (VL1) was done at the beginning of the study and the second VL (VL2) was done after one year. In our study we were more puzzled by PLHIV not show ing any sign or symptoms for variable duration of time despite of not receiving treatment. So, we choose 16 out of the 29 untreated cases in our cohort to be followed up according to their VL in conjunction with their CD4 count. The other 13 untreated cases were excluded for the following reasons, presence of comorbid infective diseases (HBV/HCV), noncompliance, and unwilling ness to participate. In scope of covering the whole spec trum of different patterns of progression, 4 treated inter esting cases were also chosen. A case with CD4 rapid decline after HIV diagnosis that dramatically improved on ART. The parents; diagnosed 17 years ago, of a family with four children, all are PLHIV. Lastly a case diag nosed and untreated for 5 years ago then underwent treatment when its CD4 started to decline.
Plasma were separated from the blood samples within 4 hours of collection and stored in a −20°C freezer. RNA extraction was performed using Qiagen QIAamp viral RNA mini spin protocol according to manufacturer instructions.
The VL for each of these samples was determined using a US FDAapproved kit (Artus HIV1 RG RT PCR kit; Qiagen, Germany).
As described by Luft, 2011;  primers were diluted to a stock concentration of 200 mM and stored at −20°C. A concentration of 2 mM for SYBR Greenbased reac tions was done. A final primer concentration of 10 pico moles/ul was able to provide highquality and con si stent results.
Gene specific primers for the most conserved region of HIV1 gag gene were chosen (Genbank) Forward: 5'ACATCAAGCAGCCATGCAAAT3' , Reverse: 5'TACTAGTAGTTCCTGCTATGTC3' . Biosystems StepOne TM Real Time PCR system was used 521 with the following conditions: one cycle of reverse tran scription at 45°C for 30 min, followed by one cycle of polymerase activation at 95°C for 5 min then 40 cycles of PCR amplification. Each cycle consisted of denatura tion at 95°C for 15 s, annealing at 55°C for 15 s, and extension at 72°C for 30 s.
CCR5 genotyping. Eight cases that fulfilled the criteria of being LTNPs (according to CD4 count, VL, duration since diagnosis and never on ART) were cho sen for genotyping for the CCR5delta32allele.
After the genomic DNA was extracted using QIA GENBloodMidiKit (Qiagen, Germany), screening of the cases for the CCR5delta32allele was performed with a genomic PCR using primers flanking the site of the deletion (forward: 5'CTCCCAGGAATCATCTTTA C3' , reverse: 5'TCATTTCGACACCGAAGCAG3'). The PCRs were performed in 50μl volumes, each com prising 2 × mixture containing 1.5 mM MgCl 2 , 10 mM dNTPS, 2.5 U Taq DNA polymerase, 50 ng genomic DNA, and 20 µmol of each primer (Gero, 2011) .
The amplification conditions were as follows: dena turation at 94°C for 1 min, followed by 35 cycles of PCR amplification. Each cycle consisted of denaturation at 94°C for 30 s, annealing at 58°C for 30 s, and extension at 72°C for 30 s. Following the 35 cycles of PCR there was an extension for 10 min at 72°C.
Results were confirmed by direct sequencing using the BigDye® Terminator 1.1. CycleSequencing Kit (Applied Biosystems, Germany).
Statistical analysis of the data. The collected data were coded and typed onto computer files. All analy ses were performed using SPSS/Pc + software program version 20.0 (Kirkpatrick and Feeny, 2013) . The level of significance selected for results was 5% (α = 0.05). Analytic statistics were carried out using ChiSquare test (X 2 ), Fisher's exact test and Student ttest were used to reveal association between characteristics of HIV infected patients and HIV progression.
Wilcoxon Signed Ranks test, Paired ttest were done to compare mean values of HIV immunological and virological markers reported at different points of time. Additionally, unemployment rate was calculated. Uni variate analysis was conducted where basic sociodemo graphic and health status characteristics were examined for association with respect to employment status, using ChiSquare test (X 2 ), Fisher's exact test, and Monte Carlo test for categorical variables, and Student ttest for quantitative variables. All variables that were signifi cantly associated with employment status in univariate analysis, were included in multivariate analysis using logistic regression model to investigate predictors of employment among the studied HIVcases.
Ethical clearance. The protocol of the current study was approved by AFH, MOH and the Medical Research Ethics Committee at AFM. Objectives of the study, expected benefits, types of information to be obtained, procedures, and publication were explained to each participant and an informed written consent was obtained before participation in the study. Moreo ver, confidentiality of data was insured.
Results
Characteristics of the studied HIV-infected patients with respect to disease progression (n = 150).
Two thirds of our study HIV infected patients were males (n = 100, 66.7%). Their age ranged from 18-62 years with mean age of (33.93 ± 9.25) years. The majority of our patients have urban residence (n = 142, 94.7%) with 46 of them (30.7%) clustered in Amryia district. As regarding HIV acquisition risk factors, family member living with HIV was present in 55.3% of cases (n = 83), of which 67.46% (n = 46) have a spouse having HIV. Addiction was found in about 29.3% (n = 44) while 24% (n = 36) were intravenous (IV) abusers.
Regarding HIV progression, based on CD4 count, duration since diagnosis and ART, RP accounted for 56% of the studied group followed by progressors, con trollers and LTNP accounting for 24.7%, 12.7% and 6.7% respectively. Among the studied group 24.6% (n = 37) had infectious comorbidity (Hepatitis B and HCV). In the treated group (80%, n = 121), Truvada + Efavirnez was the treatment regimen in 71.1% of cases and Efavirnez + Zidavudine + Lamivudine in 28.9% in cases with comorbidity.
Among different parameters, the presence of comor bidity was significantly associated with disease progres sion (X 2 = 6.61; p = 0.01) (Table I) .
Immunological makers; CD4 + T-cell count (cells/ mm 3 ) among the studied HIV-infected patients. CD4 + (4) was significantly higher than the other four readings [(CD4 + (0), CD4 + (1) CD4 + (2), CD4 + (3)] among all HIV infected patients; n = 150, and also among the treated group; n = 121, (p = 0.00 and p = 0.00 respectively) (Table II) .
Viral Load -VL (IU/ml) among the studied HIVinfected patients. VL was taken as a virological marker in the course of disease progression. Twenty cases that were chosen, showing different patterns of progression; one was RP, three intermediate were progressors, eight were controllers, 8 were LTNPs. Two LTNPs cases had VL BDL (< 50 IU/ml). VL(2) was significantly higher than VL(1) when assessing patients with detectable VL; n = 18, and also when assessing untreated patients with detectable VL; n = 14, (p = 0.00 and p = 0.00 respec tively) (Table III) .
CCR5 genotyping. PCR fragment of 200 base pairs (bp) were detected for CCR5 gene. The eight LTNP selec ted cases were found to carry the wild type of CCR5.
Characteristics of the studied HIV-infected patients with respect to patients' employment status (n = 150). Unemployment rate among HIVinfected pat ients was 40%. Most of employed HIVinfected patients were men (85.6%), while most of unemployed group were women (61.7%) (X 2 = 36.12; p = 0.00). Addi HIV -human immune deficiency virus; Z -Z value of Wilcoxon Signed Ranks test; t: paired ttest; D: standard deviation; ** -significant at p ≤ 0.01 (2tailed); " -CD4+ (0) -CD4+ (4); $ -CD4 + (1) -CD4 + (4); -CD4 + (2) -CD4 + (4); @ -CD4 + (3) -CD4 + (4); CD4 + (0) -earliest CD4 + count; CD4 + (1) -CD4 + measured at the beginning of the study; CD4 + (2) -CD4 + measured after 3 months of the study; CD4 + (3) -CD4 + measured after 6 months of the study; CD4 + (4) -CD4 + measured after 9 months of the study tionally, 41.1% and 6.7% of employed HIVinfected patients obtained vocational training and secondary school education respectively, compared with unem ployed group (11.7% and 5% respectively) ( Monte Carlo p = = 0.00). Significantly higher percentage of unemployed HIVinfected patients had family member living with 523 HIV (68.3%) compared with employed group (46.7%) (X 2 = 6.83; p = 0.00). Moreover, 34.4% of employed HIVinfected patients were PWID compared with 8.3% of unemployed group (X 2 = 13.45; p = 0.00). According to HIV progression, 17.8%, 63.3%, 4.4%, and 14.4% of employed HIVinfected patients had progressive, RP, LTNP, and controllers respectively, compared with unemployed patients (35%, 45%, 10% and 10%, respec tively), ( Monte Carlo p = 0.03) (Table IV) . Predictors of employment in the studied HIVinfected patients (n = 150) (Table V) . Characteris tics that were significantly associated with respect to employment status in univariate analysis were included in multivariate analysis using logistic regression model. The overall model was significant (model X 2 = 57.11, p = 0.00); significant predictors of employment were male gender (odds ratio [OR]: 7.29; 95% confidence interval [CI]: 2.72-19.52), and obtaining vocational training (OR: 6.04; 95%CI: 1. 81-20.16 ). According to the results, HIVinfected man was 7.3 times more likely to be employed compared with HIVinfected woman. Moreover, HIVinfected patient who obtained voca tional training was 6 times more likely to be employed than an illiterate HIVinfected patient. Although, in univariate analysis, having a family member living with HIV, PWID and HIV progression was significantly associated with employment; yet, these associations were no longer significant after adjustment for other covariates in multivariate analysis (Table V) .
Discussion
The world has committed to ending the AIDS epidemic by 2030 as declared by UNAIDS 2016. The 909090 target provides that by 2020: (a) 90% of all PLHIV will know their HIV status; (b) 90% of all peo ple with diagnosed HIV infection will receive sustained antiretroviral therapy; and (c) 90% of people receiv ing antiretroviral therapy will achieve viral suppres sion (Global gains made towards the 909090 targets UNAIDS, 2016) In the present study males accounted for two thirds of cases. Similarly, 83% of HIV infected patients HIV -human immune deficiency virus; VL -viral load; Z -Z value of Wilcoxon Signed Ranks test; ** -significant at p ≤ 0.01; VL (1) -VL measured at the beginning of the study; VL (2) -VL measured after one year of the study; d -detection level was 50 IU/ml; & -VL (1) -VL (2) for HIV patients whose viral load was above detection level (n = 18); L -VL (1) -VL (2) for HIV patients whose viral load was above detection level ( reported were males with same age range in an Egyp tian survey (Jackobsen, 2014). The majority of our patients had urban residence (94.7%) and Amrya district showed the highest clus tering (30.7%). Amrya district was also found to be the second highest district of HCV clustering in a PhD study conducted at the AFM (Gamaleldeen, 2016) .
Sexual transmission and drug abuse remain the major routes of HIV infection in MENA including Egypt (Gokengin et al., 2016) . Our results of HIV due to IV abuse is in harmony with the results of a national surveillance study showing that 28% of reported HIV infected patients in Egypt in 2010 occurred in PWID which is consistent with an epidemic that dispropor tionately affects MSM and/or PWID (NAP, HIV/AIDS biological and behavioral surveillance; 2010). Male PWID comes out to 93,314; 0.37% of the male popula tion aged 18-59 (Jackobsen, 2014) .
In the last few years, many countries in MENA have been affected by social and political unrest and conflict. However, the current HIV prevalence of 0.1% is still among the lowest rates globally (El Beih et al., 2012) . Iran has the highest numbers of PWID (185 000, 0.43%), followed by Pakistan (117 000) and Egypt (93 000) (Mumtaz et al., 2014) .
HCV is a common coinfection among PLHIV in Egypt. This is due to the high background of HCV prev alence in the general population (7%) (EHIS, 2015) . As in most countries, Egypt is adopting nucleic acid testing in blood banks to provide safe blood transfu sions (Egyptian national standards for blood trans fusion, 2011).
The development of signs and symptoms of AIDS typically parallels laboratory testing for CD4 lympho cytes. CD4 lymphocyte count, HIV VL and follow up duration are key components used to define HIV phe notypes .
In our study group, RP accounted for 56% while average percent is around 10-15% . This could be attributed to that those patients have signs and symptoms so they are more keen to show up for treatment and follow up. Also, PLHIV is In the current study, LTNP accounted for 6.7% which is similar to average estimates (5-10%) (Gur dasani et al., 2014) . EC proportion varies greatly between studies, it ranged from 0.15-7.70% according to the Concerted Action on SeroConversion on AIDS and Death in Europe (CASCADE) dataset as it did not necessarily reflect the length of followup required by the definition.
The best laboratory measure for determination of the long term progression of AIDS for therapeutic purposes is the level of HIV RNA in peripheral blood. Despite ART, the reconstitution of the immune system may be partial or incomplete, with considerable varia bility in the magnitude of the response (Gunthard et al., 2016) . CD4 count response is controversial, it mostly increases but still may remain below normal.
In our study, the significantly higher CD4+(4) count among the whole cohort and among the treated group as well as significantly higher VL (2) among the untreated group intensify the importance for ART in HIV patients.
CCR5 is a prominent cofactor for HIV1 entry. 74 mutations including the intensively studied 32 base pair deletion (CCR5delta32) were identified. We detected no deletion mutations among selected LTNP cases. Mutation occurs most frequently in the Cauca sian population, while it cannot be found in the Asian, Middle East, African, and the American Indian popula tion (Gero et al., 2011) .
In the present study, the unemployment rate among HIVinfected patients was 40%. The result coincides with unemployment rates of 45-65% reported by Dray Spira et al. (2007) and 40% reported by Rabkin et al. (2004) . However, it is much higher than unemployment rate; 12.1%, among HIVinfected patients reported in Gros et al (2016) which could be attributed to national difference; the overall unemployment rate in Rabkin et al. (2004) in Germany (4.6%) is lower than that in Egypt according to ILO, 2016 (12.7% ). Yet, results of the current research are consistent with recent studies that indicates higher unemployment rates of HIVinfected individuals compared with the background population.
On studying predictors of employment for HIV infected patients, HIVinfected men were more likely to be employed than HIVinfected women. Likewise, Dray Spira et al. (2007) , reported lower rates of employment among HIVinfected women (46.9%) compared with HIVinfected men (65.1%), however, in the current study, employment rate among women was very much lower than Dray Spira et al., 2007 (14.4% vs 46.9%) . This could be partially due to the fact that women, even in absence of HIV disease, have lower opportunity regard ing labor market participation especially in developing countries. In the general population in Egypt, unem ployment among females is 25.7%, compared with 8.9% in males (CAPMAS, 2016) .
Furthermore, in the present research, HIVinfected patients who obtained vocational training were more likely to be employed compared with illiterate HIV infected patients. Similarly, previous studies showed higher probability of labor market participation in highly educated HIVinfected individuals as described by Elzi (2016) and that poor education is significantly associated with higher unemployment rate among HIV infected patients (Gros et al., 2016) .
According to HIV/AIDS Strategic Frame 2012-2016; Egypt's goal is to stabilize the growth of the AIDS epidemic in the country, prevent new infections espe cially within the most at risk population and improve health outcomes for PLHIV. National positive response developments; most notably prevention programmes for the key populations of PWID and MSM, have been implemented. HIV testing is available for diagnostic purposes and both governmental and nongovernmental voluntary testing and counselling are being expanded. Treatment centers have been set up at fever hospitals. Stigma and discrimination are prohibited and various care and supportive measures are undertaken.
